Literature DB >> 27788580

Inorganic Nanoparticles for Image-Guided Therapy.

Hong Yeol Yoon1, Sangmin Jeon1,2, Dong Gil You1,2, Jae Hyung Park2, Ick Chan Kwon1,3, Heebeom Koo4, Kwangmeyung Kim1.   

Abstract

Recently, nanotechnology has provided significant advances in biomedical applications including diagnosis and therapy. In particular, nanoparticles have emerged as valuable outcomes of nanotechnology due to their unique physicochemical properties based on size, shape, and surface properties. Among them, a large amount of research has reported imaging and therapeutic applications using inorganic nanoparticles with special properties. Inorganic nanoparticles developed for imaging and therapy contain metal (Au), metal oxide (Fe3O4, WO3, WO2.9), semiconductor nanocrystal (quantum dots (QDs)), and lanthanide-doped upconversion nanoparticles (UCNPs). Based on their intrinsic properties, they can generate heat, reactive oxygen species (ROS), or energy transfer, so that they can be used for both imaging and therapy. In this review, we introduce biocompatible inorganic nanoparticles for image-guided thermal and photodynamic therapy, and discuss their promising results from in vitro and in vivo studies for biomedical applications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27788580     DOI: 10.1021/acs.bioconjchem.6b00512

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  12 in total

Review 1.  Careers in nanomedicine and drug delivery.

Authors:  Elizabeth Nance
Journal:  Adv Drug Deliv Rev       Date:  2019-06-28       Impact factor: 15.470

Review 2.  Role of different types of nanomaterials against diagnosis, prevention and therapy of COVID-19.

Authors:  Ferial Ghaemi; Amirhassan Amiri; Mohd Yazid Bajuri; Nor Yuliana Yuhana; Massimiliano Ferrara
Journal:  Sustain Cities Soc       Date:  2021-05-25       Impact factor: 7.587

3.  Enhancement of saquinavir absorption and accumulation through the formation of solid drug nanoparticles.

Authors:  Gabriel Kigen; Geoffrey Edwards
Journal:  BMC Pharmacol Toxicol       Date:  2018-12-04       Impact factor: 2.483

Review 4.  Mapping of the available standards against the regulatory needs for nanomedicines.

Authors:  Blanka Halamoda-Kenzaoui; Uwe Holzwarth; Gert Roebben; Alessia Bogni; Susanne Bremer-Hoffmann
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-06-20

Review 5.  MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders.

Authors:  Dong Han; Xiaoyu Dong; Dongming Zheng; Jianfei Nao
Journal:  Front Pharmacol       Date:  2020-01-17       Impact factor: 5.810

Review 6.  Use of Polyhedral Oligomeric Silsesquioxane (POSS) in Drug Delivery, Photodynamic Therapy and Bioimaging.

Authors:  Paula Loman-Cortes; Tamanna Binte Huq; Juan L Vivero-Escoto
Journal:  Molecules       Date:  2021-10-26       Impact factor: 4.411

Review 7.  Review on Nanoparticles and Nanostructured Materials: Bioimaging, Biosensing, Drug Delivery, Tissue Engineering, Antimicrobial, and Agro-Food Applications.

Authors:  Vancha Harish; Devesh Tewari; Manish Gaur; Awadh Bihari Yadav; Shiv Swaroop; Mikhael Bechelany; Ahmed Barhoum
Journal:  Nanomaterials (Basel)       Date:  2022-01-28       Impact factor: 5.076

Review 8.  Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients.

Authors:  Rasha Itani; Mansour Tobaiqy; Achraf Al Faraj
Journal:  Theranostics       Date:  2020-05-01       Impact factor: 11.556

Review 9.  Multifunctional phototheranostic nanomedicine for cancer imaging and treatment.

Authors:  D Gao; X Guo; X Zhang; S Chen; Y Wang; T Chen; G Huang; Y Gao; Z Tian; Z Yang
Journal:  Mater Today Bio       Date:  2019-11-06

10.  The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy.

Authors:  Xiaoli Zhang; Tian Zhang; Xianbin Ma; Yajun Wang; Yi Lu; Die Jia; Xiaohua Huang; Jiucun Chen; Zhigang Xu; Feiqiu Wen
Journal:  Asian J Pharm Sci       Date:  2019-11-06       Impact factor: 6.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.